Alzheimer's Wisconsin

Earlier this month, Walk to End Alzheimer’s participant Mark Schuster threw out the first pitch at the @Brewers game! ⚾ Mark was the top fundraiser in Wisconsin during the month of May, raising $8,000 and earning the opportunity to take the mound. A huge thank you to Brewers for helping us turn American Family Field purple. 💜 #ENDALZ #Walk2EndAlz #ThisIsMyCrew

Ahead of tonight’s @Brewers game, #Walk2EndAlz participant Mark Schuster threw out the first pitch! Mark was the top fundraiser in Wisconsin during the month of May, raising $8,000 and earning the opportunity to take the mound. A huge thank you to Brewers for helping us turn American Family Field purple tonight. #ENDALZ #ThisIsMyCrew

The FDA has cleared the first blood test for Alzheimer’s for use in primary care settings specifically to rule out the presence of amyloid, a hallmark of the disease. “This is another important step toward expanding access to Alzheimer’s disease diagnostic tools,” said our president and chief executive officer @joannepikedrph. The blood test is intended to help primary care physicians determine which patients do not require Alzheimer’s-related follow-up tests, such as PET scans or cerebrospinal fluid analysis. This can significantly improve the diagnostic process by preventing unnecessary specialized testing for individuals whose cognitive issues stem from non-Alzheimer’s causes. The Association is committed to ensuring blood tests are used appropriately and effectively across all care settings. Read our full statement: bit.ly/4oh3Tiu.

BREAKING: Results from U.S. POINTER, reported today at #AAIC25, show that lifestyle interventions that simultaneously target risk factors protect cognitive function in older adults at increased risk for cognitive decline and dementia — protecting cognition from normal age-related decline for up to two years. bit.ly/USPointerRelease

The bipartisan BOLD Alzheimer’s program is at risk. Take action NOW to urge your members of Congress to defend BOLD and continue strengthening our nation’s public health response to Alzheimer’s: bit.ly/42q2Qoi. #BOLDAlzheimersAct

Cuts made today by the Department of Health and Human Services (HHS) may undermine our nation’s response to the dementia public health crisis. Read our statement: bit.ly/43BtxHU.

BREAKING NEWS: The Senate has unanimously passed the bipartisan #BOLDAlzheimersAct 🎆 Thank you, advocates, for your hard work to advance this critical legislation. Next up: The bill will head to the president’s desk to be signed into law! bit.ly/493jrA5

We did it, advocates! 🎆 The bipartisan NAPA Reauthorization Act and Alzheimer's Investment Act have been signed into law. These critical bills will renew our nation's commitment to addressing Alzheimer's by supporting research and improving the delivery of clinical care and services for people impacted by the disease. Thank you, advocates, for making this milestone moment possible. You met with your members, sent emails, picked up the phone and grew support on social media and beyond. This victory is yours. bit.ly/3NaiUSJ #NAPAAct #AlzInvestmentAct #ENDALZ

Great news from Capitol Hill! The House unanimously passed the bipartisan #NAPAAct and #AlzInvestmentAct! 🎆 These important bills are now on their way to the president’s desk for a signature because advocates like YOU made your voices heard.